mantralabsglobal.com
Mixed Reality (MR) also known as “hybrid reality” and “extended reality,” has the potential to change just about every industry, healthcare being no exception. A combination of Virtual Reality (VR), Augmented Reality (AR), and Artificial Intelligence (AI); MR is emerging as a tech to create experiences that blend the real-life environment with digital elements.
Watch Now
Halo Labs
Subvisible particle analysis is a key predictor of protein drug stability and a key formulation, quality metric. However, current methods use large volumes of precious protein solutions and are labor- and time-intensive, making this data inaccessible during late-stage candidate screening or early in formulation. Moreover, regulatory agencies are tightly enforcing subvisible particle content in biopharma formulations at unprecedented levels, making early detection of subvisible particles, like protein aggregates, a key analytical priority.
Watch Now
merckmillipore
According to market research, DNA and RNA therapeutics are growing at 12% CAGR and expected to reach $1.2 billion by 2020. This webinar reviews the current dynamics in the RNA therapeutics/vaccines market and focuses on process development and manufacturing strategies.
Watch Now
The recently published revision to Eudralex Vol. 4 Annex 1, clarified current expectations for manufacture of sterile medicinal products in light of improved process understanding and advances in processing technologies.
Watch Now